Kevin Zarrabi - Sidney Kimmel Canc Ctr, Thomas Jefferson Univ

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Enhancing the Immunogenicity of Nivolumab Plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma

Kevin K. Zarrabi,Ulka Vaishampayan,Pedro C. Barata

European Urology Focus (2025)

引用0浏览0WOS引用

Tumor-associated Antigen Targets for Novel Immune-Based Strategies in Prostate Cancer

Amman Bhasin,Patrick J. Mille,Aditya Eturi, Andrew Iskander,William Tester,Kevin K. Zarrabi

JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICSno. 1 (2024): 55-76

引用0浏览0引用

Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau

Aaron R. Hochberg,Patrick T. Gomella,Brian Im,Anushka Ghosh,Sohan Shah, Rasheed A. M. Thompson,Kevin K. Zarrabi,Mihir S. Shah,J. Ryan Mark,Joseph K. Izes,Costas D. Lallas,Leonard G. Gomella,Adam R. Metwalli

JOURNAL OF KIDNEY CANCER AND VHLno. 4 (2024): 28-38

引用0浏览0WOS引用

Association of Acute Rejection and De Novo Renal Cell Carcinoma in Kidney Transplant Patients: an OPTN Data Analysis

Molly E. Casey, Emmalie Yanacek, Hitesh Kaul,John P. Knorr,Kamran Khanmoradi,Afshin Parsikia,Nikolaos Chandolias,Kevin K. Zarrabi,Radi Zaki

Transplantologyno. 4 (2024): 280-287

引用0浏览0引用

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

Prostate Cancer and Prostatic Diseasespp.1-9, (2024)

引用2浏览0WOSNATURE引用

Therapy with Metronomic Cyclophosphamide (mcyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (Mcrpc)

Nataliya Mar,Sami Dwabe, Marlon N. Baranda,Kevin K. Zarrabi,Aditya Eturi,Shuchi Gulati,Mamta Parikh,Steven N. Seyedin,Arash Rezazadeh Kalebasty

CLINICAL GENITOURINARY CANCERno. 2 (2024): 217-223

引用1浏览0WOS引用

Pure Squamous Cell Carcinoma of the Prostate with a Complete Remission to Gemcitabine-Cisplatin: Case Presentation and Literature Review

Yang, Yilin Shen,Kevin K. Zarrabi, Yutao Deng,William Tester

JU Open Plusno. 10 (2024)

引用0浏览0引用

Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers

Pedro C. Barata,Kevin K. Zarrabi,Axel Bex,Petros Grivas, Ken Hermann,Michael S. Hofman,Roger Li, Antonio Lopez-Beltran, Anwar R. Padani,Thomas Powles,Mary-Ellen Taplin,Yohann Loriot

European Urology (2024)

引用0浏览0WOS引用

Contemporary Role of Avelumab First-Line Maintenance in Advanced Urothelial Carcinoma with Consideration of the JAVELIN Bladder 100 Comprehensive Clinical Subgroup Analyses

Kevin K. Zarrabi,Benjamin Miron,Daniel M. Geynisman

Translational andrology and urology（2024）

引用0浏览0WOS引用

Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma

Aditya Eturi,Amman Bhasin,Kevin K. Zarrabi,William J. Tester

Moleculesno. 8 (2024): 1896-1896

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn